Home » BAYER SELLS DIAGNOSTIC BUSINESS TO SIEMENS

BAYER SELLS DIAGNOSTIC BUSINESS TO SIEMENS

June 30, 2006

Bayer Diagnostics India Ltd will become a part of the Siemens Group, following the worldwide sale of the Bayer Group's diagnostic business to Simens AG for a price of 4.2 billion Euros.
The Hindu

KEYWORDS FDAnews Device Daily Bulletin

08Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
13Sep
Trial Master File Inspection Readiness: From Chaos to Calm
14Sep
Omnichannel Engagement: Are You Digitally Ready?
15Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

BAYER SELLS DIAGNOSTIC BUSINESS TO SIEMENS

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Trial Master File Inspection Readiness: From Chaos to Calm

Omnichannel Engagement: Are You Digitally Ready?

Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

Guardant Health Receives FDA Approval for Guardant360 CDx Liquid Biopsy Test

Genentech Inks Licensing Deal With Jemincare Over Androgen Receptor Degrader

FDA Clears Thermo Fisher Scientific’s Wheat and Sesame Allergy Tests

The Revised ICH E8: A Guide to New Clinical Trial Requirements